tirzepatide summit trial Reaching the SUMMIT? Benefits and potential risks associated with the use of in heart failure with preserved ejection fraction ๐ Most viewed this week
Pay in 4 interest-free payments of $5.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 1 - Aug 6
Live Spec
Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all cause mortality vs sitagliptin, but tirzepatide offered no Tirzepatide Meets Both Primary End Points in Phase 3 SUMMIT Trial Pharmacy Times tirzepatide cardiovascular outcomes trial Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular AHA 24 Late Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity SURMOUNT 1 Trial Cardionerds Twitter Journal Club
Store: skorenge.com ยท Domain: skorenge.com



























